Where Early-Stage Life Sciences Companies Get Stuck Scaling Their Real Estate—and How to Move Forward (Source: Area Development)

Biotech firms face delays in programming, permitting, and infrastructure as they scale from lab to production.

Labspace Directory co-founders David Klein, Esq. (Inactive), CCIM, SIOR, LEED AP, MCR and Elijah (E.J.) Hodges break down where lab-to-production transitions go wrong, and why today's market conditions favor tenants who plan ahead. From underestimating programming timelines to over-relying on incubator space, the piece maps the most common missteps for early-stage biomanufacturing companies and how to avoid them.

Read the full article at Area Development: Where Early-Stage Life Sciences Companies Get Stuck Scaling Their Real Estate—and How to Move Forward.